What the mice showed
In the studies by Dalmasso and Kannengiesser in 2008, KPV reduced bowel inflammation in mice.
Kannengiesser’s study also reported an earlier return of body weight in the treated mice.
These were deliberately created forms of bowel inflammation in animals, rather than care for people with bowel disease.
What a gut claim leaves out
The FDA, the US Food and Drug Administration, found no studies giving KPV to people with bowel disease, as of September 28, 2026.
The mouse findings do not establish a gut-healing benefit in a person.
“Gut health” is a broad phrase. Ask what specific problem the claim is meant to address.
Bring symptoms, not just a product name
Describe the bowel problem in your own words at a health visit. Include when it started, what changes it and what care you have already had.
Ask what needs to be assessed before discussing treatment. If a study is offered as proof, ask whether living people received KPV in it.